Table 4.
Follow up data of patients with PCA.
| Initial | ≤ 12 M | 12–24 M | > 24 M | p-value | |
|---|---|---|---|---|---|
|
Number n |
19 | 7 | 8 | 10 | |
|
PSA Median (IQR) ng/ml |
6 (6–9.2) | 5.5 (5.4–8.2) | 6.9 (5.4–9.1) | 8.5 (6.1–11.1) | 0.52 |
|
PSAD Median (IQR), ng/ml/cm3 |
0.13 (0.13–0.18) | 0.12 (0.09–0.16) | 0.13 (0.11–0.15) | 0.18 (0.13–0.22) | < 0.001 |
|
Volume Median (IQR), ml |
46 (46–65.5) | 48 (46–61) | 50 (31–66) | 57 (38–73) | 0.08 |
|
PI-RADS Median (mean) |
3 (3.0) | 3 (3.43) | 4 (3.88) | 3 (3.30) | 0.02 |
|
M Mean ± SD |
9 ± 2 | 14 ± 2 | 39 ± 13 | ||
PSA value: prostate specific antigen; PSAD: prostate specific antigen density; PI-RADS: Prostate Imaging Reporting and Data System; IQR: interquartile range; M: months; n: number.
Significant values are given in bold.